We are live on
!
Find out more
WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Est. Return
42.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.28%
3 Year Est. Return
+149.38%
5 Year Est. Return
+174.91%
10 Year Est. Return
+944.06%
AUM
$30B
AUM Growth
+$2.11B
(+7.6%)
Cap. Flow
+$978M
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
45.43%
Holding
227
New
32
Increased
69
Reduced
105
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICICI Bank
IBN
|
+$1.3B |
| 2 |
Atlassian
TEAM
|
+$577M |
| 3 |
Corteva
CTVA
|
+$284M |
| 4 |
Booz Allen Hamilton
BAH
|
+$281M |
| 5 |
Datadog
DDOG
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$515M |
| 2 |
ASML
ASML
|
+$512M |
| 3 |
ResMed
RMD
|
+$436M |
| 4 |
Graco
GGG
|
+$394M |
| 5 |
West Pharmaceutical
WST
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.62% |
| 2 | Technology | 26.75% |
| 3 | Industrials | 18.3% |
| 4 | Financials | 16.46% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
151
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.43M | 0.02% |
+587,563
| New | +$7.46M |
|
152
Health Catalyst
HCAT
$129M
| $6.27M | 0.02% |
589,371
-10,130
| -2% | -$97.8K |
|
153
Arrowhead Research
ARWR
$12.5B
| $5.97M | 0.02% |
147,102
+70,282
| +91% | +$2.33M |
|
154
Shopify
SHOP
$200B
| $5.82M | 0.02% |
167,732
+8,420
| +5% | +$288K |
|
155
GoDaddy
GDDY
$11.6B
| $5.61M | 0.02% |
74,948
+60,293
| +411% | +$4.52M |
|
156
Brown & Brown
BRO
$24B
| $5.49M | 0.02% |
96,418
+77,287
| +404% | +$4.52M |
|
157
Insmed
INSM
$29.4B
| $5.19M | 0.02% |
259,711
-3,595
| -1% | -$69.5K |
|
158
Natera
NTRA
$45.9B
| $5.19M | 0.02% |
129,145
-1,949
| -1% | -$80.3K |
|
159
iShares MSCI EAFE Growth ETF
EFG
$17.2B
| $5.11M | 0.02% |
+61,049
| New | +$4.94M |
|
160
Rocket Pharmaceuticals
RCKT
$397M
| $4.93M | 0.02% |
251,698
-139,232
| -36% | -$2.56M |
|
161
Clarus
CLAR
$145M
| $4.9M | 0.02% |
624,589
-8,469
| -1% | -$82.5K |
|
162
CryoPort
CYRX
$751M
| $4.8M | 0.02% |
276,740
+4,497
| +2% | +$94.8K |
|
163
Ultragenyx Pharmaceutical
RARE
$2.64B
| $4.48M | 0.02% |
96,770
+6,715
| +7% | +$264K |
|
164
Yeti Holdings
YETI
$3.99B
| $4.4M | 0.01% |
+106,547
| New | +$4M |
|
165
Lincoln Electric
LECO
$15.1B
| $4.3M | 0.01% |
29,759
+23,750
| +395% | +$3.33M |
|
166
Keros Therapeutics
KROS
$212M
| $3.99M | 0.01% |
+83,141
| New | +$3.88M |
|
|
167
Graco
GGG
$13.5B
| $3.9M | 0.01% |
57,942
-5,908,138
| -99% | -$394M |
|
168
PTC
PTC
$16.4B
| $3.86M | 0.01% |
32,129
+24,840
| +341% | +$2.97M |
|
|
NSTG
169
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.8M | 0.01% |
476,785
+214,854
| +82% | +$1.86M |
|
170
MKS Inc
MKSI
$19.8B
| $3.75M | 0.01% |
+44,271
| New | +$3.55M |
|
171
Jones Lang LaSalle
JLL
$16.4B
| $3.7M | 0.01% |
23,223
+18,483
| +390% | +$2.95M |
|
172
Watsco Inc
WSO
$13.5B
| $3.65M | 0.01% |
14,655
+11,793
| +412% | +$3.1M |
|
173
Monster Beverage
MNST
$89.6B
| $3.51M | 0.01% |
+138,404
| New | +$3.35M |
|
174
Masco
MAS
$14.7B
| $3.29M | 0.01% |
+70,531
| New | +$3.4M |
|
175
iShares ESG Aware MSCI EM ETF
ESGE
$6.69B
| $3.01M | 0.01% |
+100,000
| New | +$2.93M |
|
Similar funds
LP
WCM Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, WCM Investment Management held 227 positions worth $30B, up 7.6% from $27.9B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
WCM Investment Management deployed $978M of net new capital in Q4 2022, opening 32 new positions and adding to 69 existing holdings. Its largest new stake was Thomson Reuters: 1,686,848 shares worth $203M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was lululemon athletica, an estimated $515M trimmed.
- WCM Investment Management's largest Q4 2022 buy was Thomson Reuters: 1,686,848 shares worth $203M.
- WCM Investment Management added most to ICICI Bank in Q4 2022, an estimated $1.3B increase.
- WCM Investment Management's biggest Q4 2022 reduction was lululemon athletica, cutting an estimated $515M.
- WCM Investment Management fully exited West Pharmaceutical in Q4 2022, selling an estimated $311M.
- WCM Investment Management's ten largest holdings make up 45% of its $30B portfolio in Q4 2022.
- WCM Investment Management opened 32 new positions and closed 14 in Q4 2022.
- WCM Investment Management's portfolio value rose 7.6% quarter-over-quarter to $30B.
Based on WCM Investment Management's 13F filing for Q4 2022, filed 7 Feb 2023.